Ruben A. Goedegebuure

Amersfoort, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancer.

Adenocarcinoma of the small intestine cohort: prospectively collecting real-world data to improve care and quality of life for patients with a rare cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 28, 2026

Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.

Effects of exercise and diet in patients with incurable gastroesophageal cancer: the RADICES study.

Journal: JNCI cancer spectrum

Published: August 29, 2025

Malignancies of the small intestine: incidence and trends in a nationwide registry.

Malignancies of the small intestine: incidence and trends in a nationwide registry.

Journal: Cancer epidemiology

Published: July 01, 2025

Treatment with checkpoint inhibitors for unresectable non-metastatic mismatch repair deficient intestinal cancer; a case series.

Treatment with checkpoint inhibitors for unresectable non-metastatic mismatch repair deficient intestinal cancer; a case series.

Journal: BJC reports

Published: December 17, 2024

Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort.

Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort.

Journal: Journal of the National Cancer Institute

Published: May 02, 2024

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.

Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.

Journal: Frontiers in immunology

Published: January 17, 2024

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.

Journal: Oncoimmunology

Published: August 11, 2021

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.

Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 17, 2021

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.

Journal: Molecular oncology

Published: October 28, 2020

A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies.

A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies.

Journal: The oncologist

Published: September 24, 2020

Combining Radiation Therapy With Interferons: Back to the Future.

Combining Radiation Therapy With Interferons: Back to the Future.

Journal: International journal of radiation oncology, biology, physics

Published: November 04, 2019

Development of transient radioresistance during fractionated irradiation in vitro.

Development of transient radioresistance during fractionated irradiation in vitro.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 11, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026